Enzyme Replacement Therapy Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Alglucosidasealfa, Agalsidase, Pancrelipase, Idursulfase, Laronidase, Imiglucerase, Elosulfasealfa, Asfotasealfa, Galsulfase, Velaglucerasealfa, and Others), By Route of Administration (Parenteral and Oral), By Indication (Type 1 Gaucher Disease, Pompe Disease, MPS (Mucopolysaccharidosis), Exocrine Pancreatic Insufficiency (EPI), Fabry Disease, Hypophosphatasia, and Others), By End-User (Hospitals and Homecare Settings & Infusion Centers), and Regional Forecast 2021-2028
Report Id | License Type | Price |
---|---|---|
FBI106424 | $ 4850 | |
Total | $ 4850 |